INDEMNITY AGREEMENTIndemnity Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals • Delaware
This Indemnity Agreement, dated as of , 2010 is made by and between Amyris Biotechnologies, Inc., a Delaware corporation (the “Company”), and , a director, officer or key employee of the Company or one of the Company’s subsidiaries or other service provider who satisfies the definition of Indemnifiable Person set forth below (“Indemnitee”).
AMYRIS, INC. SERIES D PREFERRED STOCK PURCHASE AGREEMENTSeries D Preferred Stock Purchase Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals • Delaware
THIS SERIES D PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of June 21, 2010, by and among Amyris, Inc., a Delaware corporation (the “Company”), and the investor listed on Schedule A hereto, which investor is herein referred to as the “Investor”.
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL...Investment Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals
This Investment Agreement (this “Agreement”) is executed on December 22, 2009 (the “Effective Date”), by the following parties (all of them, collectively, the “Parties” and individually, a “Party”):
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL...Investment Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals
This Investment Agreement (this “Agreement”) is executed on May 26, 2010 (the “Effective Date”), by the following parties (all of them, collectively, the “Parties” and individually, a “Party”):
AMYRIS, INC. AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals • California
THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of June 21, 2010, by and among Amyris, Inc., a Delaware corporation (the “Company”), and the holders of Series A Preferred Stock listed on Exhibit A attached hereto (the “Series A Preferred Stock”), the Series B Preferred Stock listed on Exhibit B attached hereto (the “Series B Preferred Stock”), the Series B-1 Preferred Stock listed on Exhibit C attached hereto (the “Series B-1 Preferred Stock”), the Series C Preferred Stock listed on Exhibit D attached hereto (the “Series C Preferred Stock”), the Series C-1 Preferred Stock listed on Exhibit E attached hereto (the “Series C-1 Preferred Stock”, the Series D Preferred Stock listed on Exhibit F attached hereto (the “Series D Preferred Stock”, and together with the Series A Preferred Stock, the Series B Preferred Stock, the Series B-1 Preferred Stock, the Series C Preferred Stock and the Series C-1 Preferred Stock, the “Preferred Stock”) (each, an “Investo
AMENDMENT AND RESTATEMENT TO THE SHAREHOLDERS’ AGREEMENT BY FUNDO MÚTUO DE INVESTIMENTOS EM EMPRESAS EMERGENTES INOVADORAS STRATUS GC III, RED MOUNTAIN JET LLC, AMYRIS BIOTECHNOLOGIES, INC., AND, AS INTERVENING PARTIES, AMYRIS BRASIL S.A. AND STRATUS...Shareholders’ Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals
This amendment and restatement to the Shareholders’ Agreement (this “Amendment”) is executed on May 26, 2010, by the following parties (all of them, collectively, the “Parties”, and individually, a “Party”):
CONFIDENTIAL TREATMENT REQUESTED. CERTAIN PORTIONS OF THIS DOCUMENT HAVE BEEN OMITTED PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT AND, WHERE APPLICABLE, HAVE BEEN MARKED WITH AN ASTERISK TO DENOTE WHERE OMISSIONS HAVE BEEN MADE. THE CONFIDENTIAL...Letter Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals
Reference is hereby made to that certain Series D Preferred Stock Purchase Agreement, dated as of June 21, 2010 (the “Series D Agreement”), by and among the Company and Total G&P (as the Investor).
AGREEMENT BY FUNDO MUTUO DE INVESTIMENTO EM EMPRESAS EMERGENTES INOVADORAS STRATUS GC III. AMYRIS BIOTECHNOLOGIES. INC., AMYRIS BRASIL S.A. AND, AS INTERVENING PARTY, STRATUS INVESTIMENTOS LTDA.Investment Agreement • June 23rd, 2010 • Amyris, Inc. • Industrial organic chemicals
This agreement (this “Agreement”) is executed on March 3rd, 2010 (the “Effective Date”), by the following parties (all of them, collectively, the “Parties” and individually, a “Party”):
